Le Lézard
Classified in: Health
Subject: SVY

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary

Download the full report: https://www.reportbuyer.com/product/4465333

GlobalData's Medical Devices sector report, "Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017" provides an overview of Synthetic Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Synthetic Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

- Extensive coverage of the Synthetic Bone Graft Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/4465333

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

These press releases may also interest you

at 10:00
TeamHealth, a leading clinician services organization, announced today that Lynn Massingale, MD, co-founder and chairman of TeamHealth, was named among the "50 Most Influential Physician Executives and Leaders" by Modern Healthcare for 2018. This is...

at 10:00
The Pennsylvania Patient Safety Authority welcomes two new members and a new Chair to its Board of Directors. Dr. Stanton Smullens, a board member since the Authority's inception and former Chief Medical Officer of the...

at 10:00
National Indigenous Peoples Day is a time to honour the heritage, contributions and cultures of First Nation, Inuit and Métis people. It also is a day to embrace reconciliation, as individuals, organizations and communities....

at 10:00
The New Jersey Senate will be honoring Elaine Pozycki for her leadership in addressing New Jersey's opioid epidemic by presenting a resolution at 2 p.m. today at the Statehouse. Elaine, co-chair of the Partnership for a...

at 10:00
A pilot program in Philadelphia community health centers is teaching patients to approach happiness as a learned skill, rather than a fleeting emotion. The goal, according to psychologists and osteopathic physicians, is to boost their mood and...

at 10:00
FARMINGTON, Calif., June 21, 2018 /PRNewswire-PRWeb/ -- LambdaVision Incorporated, a biotech company specializing in developing a treatment for patients blinded by retinal degenerative diseases, today announced the addition of Pauline Murphy of...

News published on 6 october 2017 at 09:56 and distributed by: